{
    "_id": "36400544|None",
    "id": "36400544",
    "infons": {},
    "passages": [
        {
            "infons": {
                "journal": "Hematol Oncol Clin North Am. 2022 Dec;36(6):1285-1312. doi: ",
                "year": "2022",
                "type": "title",
                "authors": "Rai P, Desai PC, Ataga KI"
            },
            "offset": 0,
            "text": "The Evolving Landscape of Drug Therapies for Sickle Cell Disease.",
            "sentences": [],
            "annotations": [
                {
                    "id": "1",
                    "infons": {
                        "identifier": "MESH:D000755",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D000755"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D000755",
                        "biotype": "disease",
                        "name": "Anemia Sickle Cell",
                        "accession": "@DISEASE_Anemia_Sickle_Cell"
                    },
                    "text": "Sickle Cell Disease",
                    "locations": [
                        {
                            "offset": 45,
                            "length": 19
                        }
                    ]
                }
            ],
            "relations": []
        },
        {
            "infons": {
                "type": "abstract"
            },
            "offset": 66,
            "text": "Although sickle cell disease can be cured using allogeneic hematopoietic stem cell transplantation and possibly gene therapy and gene editing, these treatments remain unavailable to most patients. As understanding of the disease pathophysiology increases, progress is being made in developing drug therapies. Hydroxyurea, l-glutamine, crizanlizumab, and voxelotor are currently approved by the US Food and Drug Administration, with multiple others at various stages of testing. With the limited efficacy of individual agents, combinations of agents will likely be required for optimal outcomes. Clinical and surrogate endpoints, other than vaso-occlusive crisis, are increasingly being considered in the evaluation of novel drugs.",
            "sentences": [],
            "annotations": [
                {
                    "id": "9",
                    "infons": {
                        "identifier": "MESH:D000755",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D000755"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D000755",
                        "biotype": "disease",
                        "name": "Anemia Sickle Cell",
                        "accession": "@DISEASE_Anemia_Sickle_Cell"
                    },
                    "text": "sickle cell disease",
                    "locations": [
                        {
                            "offset": 75,
                            "length": 19
                        }
                    ]
                },
                {
                    "id": "10",
                    "infons": {
                        "identifier": "9606",
                        "type": "Species",
                        "valid": true,
                        "normalized": [
                            9606
                        ],
                        "database": "ncbi_taxonomy",
                        "normalized_id": 9606,
                        "biotype": "species",
                        "name": "9606",
                        "accession": null
                    },
                    "text": "patients",
                    "locations": [
                        {
                            "offset": 253,
                            "length": 8
                        }
                    ]
                },
                {
                    "id": "11",
                    "infons": {
                        "identifier": "MESH:D006918",
                        "type": "Chemical",
                        "valid": true,
                        "normalized": [
                            "D006918"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D006918",
                        "biotype": "chemical",
                        "name": "Hydroxyurea",
                        "accession": "@CHEMICAL_Hydroxyurea"
                    },
                    "text": "Hydroxyurea",
                    "locations": [
                        {
                            "offset": 375,
                            "length": 11
                        }
                    ]
                },
                {
                    "id": "12",
                    "infons": {
                        "identifier": "MESH:D005973",
                        "type": "Chemical",
                        "valid": true,
                        "normalized": [
                            "D005973"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D005973",
                        "biotype": "chemical",
                        "name": "Glutamine",
                        "accession": "@CHEMICAL_Glutamine"
                    },
                    "text": "l-glutamine",
                    "locations": [
                        {
                            "offset": 388,
                            "length": 11
                        }
                    ]
                },
                {
                    "id": "13",
                    "infons": {
                        "identifier": "MESH:C000614139",
                        "type": "Chemical",
                        "valid": true,
                        "normalized": [
                            "C000614139"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C000614139",
                        "biotype": "chemical",
                        "name": "crizanlizumab",
                        "accession": "@CHEMICAL_crizanlizumab"
                    },
                    "text": "crizanlizumab",
                    "locations": [
                        {
                            "offset": 401,
                            "length": 13
                        }
                    ]
                },
                {
                    "id": "14",
                    "infons": {
                        "identifier": "MESH:C000628792",
                        "type": "Chemical",
                        "valid": true,
                        "normalized": [
                            "C000628792"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "C000628792",
                        "biotype": "chemical",
                        "name": "voxelotor",
                        "accession": "@CHEMICAL_voxelotor"
                    },
                    "text": "voxelotor",
                    "locations": [
                        {
                            "offset": 420,
                            "length": 9
                        }
                    ]
                },
                {
                    "id": "15",
                    "infons": {
                        "identifier": "MESH:D001157",
                        "type": "Disease",
                        "valid": true,
                        "normalized": [
                            "D001157"
                        ],
                        "database": "ncbi_mesh",
                        "normalized_id": "D001157",
                        "biotype": "disease",
                        "name": "Arterial Occlusive Diseases",
                        "accession": "@DISEASE_Arterial_Occlusive_Diseases"
                    },
                    "text": "vaso-occlusive crisis",
                    "locations": [
                        {
                            "offset": 706,
                            "length": 21
                        }
                    ]
                }
            ],
            "relations": []
        }
    ],
    "relations": [
        {
            "id": "R1",
            "infons": {
                "score": "0.5061",
                "role1": {
                    "identifier": "MESH:D006918",
                    "type": "Chemical",
                    "valid": true,
                    "normalized": [
                        "D006918"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D006918",
                    "biotype": "chemical",
                    "name": "Hydroxyurea",
                    "accession": "@CHEMICAL_Hydroxyurea"
                },
                "role2": {
                    "identifier": "MESH:D001157",
                    "type": "Disease",
                    "valid": true,
                    "normalized": [
                        "D001157"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D001157",
                    "biotype": "disease",
                    "name": "Arterial Occlusive Diseases",
                    "accession": "@DISEASE_Arterial_Occlusive_Diseases"
                },
                "type": "Negative_Correlation"
            },
            "nodes": [
                {
                    "refid": "0",
                    "role": "3,7"
                }
            ]
        },
        {
            "id": "R2",
            "infons": {
                "score": "0.9982",
                "role1": {
                    "identifier": "MESH:D006918",
                    "type": "Chemical",
                    "valid": true,
                    "normalized": [
                        "D006918"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D006918",
                    "biotype": "chemical",
                    "name": "Hydroxyurea",
                    "accession": "@CHEMICAL_Hydroxyurea"
                },
                "role2": {
                    "identifier": "MESH:D000755",
                    "type": "Disease",
                    "valid": true,
                    "normalized": [
                        "D000755"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D000755",
                    "biotype": "disease",
                    "name": "Anemia Sickle Cell",
                    "accession": "@DISEASE_Anemia_Sickle_Cell"
                },
                "type": "Negative_Correlation"
            },
            "nodes": [
                {
                    "refid": "1",
                    "role": "3,1"
                }
            ]
        },
        {
            "id": "R3",
            "infons": {
                "score": "0.9968",
                "role1": {
                    "identifier": "MESH:D005973",
                    "type": "Chemical",
                    "valid": true,
                    "normalized": [
                        "D005973"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D005973",
                    "biotype": "chemical",
                    "name": "Glutamine",
                    "accession": "@CHEMICAL_Glutamine"
                },
                "role2": {
                    "identifier": "MESH:D000755",
                    "type": "Disease",
                    "valid": true,
                    "normalized": [
                        "D000755"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D000755",
                    "biotype": "disease",
                    "name": "Anemia Sickle Cell",
                    "accession": "@DISEASE_Anemia_Sickle_Cell"
                },
                "type": "Negative_Correlation"
            },
            "nodes": [
                {
                    "refid": "2",
                    "role": "4,1"
                }
            ]
        },
        {
            "id": "R4",
            "infons": {
                "score": "0.9959",
                "role1": {
                    "identifier": "MESH:C000614139",
                    "type": "Chemical",
                    "valid": true,
                    "normalized": [
                        "C000614139"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "C000614139",
                    "biotype": "chemical",
                    "name": "crizanlizumab",
                    "accession": "@CHEMICAL_crizanlizumab"
                },
                "role2": {
                    "identifier": "MESH:D000755",
                    "type": "Disease",
                    "valid": true,
                    "normalized": [
                        "D000755"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D000755",
                    "biotype": "disease",
                    "name": "Anemia Sickle Cell",
                    "accession": "@DISEASE_Anemia_Sickle_Cell"
                },
                "type": "Negative_Correlation"
            },
            "nodes": [
                {
                    "refid": "3",
                    "role": "5,1"
                }
            ]
        },
        {
            "id": "R5",
            "infons": {
                "score": "0.9828",
                "role1": {
                    "identifier": "MESH:C000628792",
                    "type": "Chemical",
                    "valid": true,
                    "normalized": [
                        "C000628792"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "C000628792",
                    "biotype": "chemical",
                    "name": "voxelotor",
                    "accession": "@CHEMICAL_voxelotor"
                },
                "role2": {
                    "identifier": "MESH:D000755",
                    "type": "Disease",
                    "valid": true,
                    "normalized": [
                        "D000755"
                    ],
                    "database": "ncbi_mesh",
                    "normalized_id": "D000755",
                    "biotype": "disease",
                    "name": "Anemia Sickle Cell",
                    "accession": "@DISEASE_Anemia_Sickle_Cell"
                },
                "type": "Negative_Correlation"
            },
            "nodes": [
                {
                    "refid": "4",
                    "role": "6,1"
                }
            ]
        }
    ],
    "pmid": 36400544,
    "pmcid": null,
    "meta": {},
    "date": "2022-12-01T00:00:00Z",
    "journal": "Hematol Oncol Clin North Am",
    "authors": [
        "Rai P",
        "Desai PC",
        "Ataga KI"
    ],
    "relations_display": [
        {
            "name": "treat|@CHEMICAL_Hydroxyurea|@DISEASE_Arterial_Occlusive_Diseases"
        },
        {
            "name": "treat|@CHEMICAL_Hydroxyurea|@DISEASE_Anemia_Sickle_Cell"
        },
        {
            "name": "treat|@CHEMICAL_Glutamine|@DISEASE_Anemia_Sickle_Cell"
        },
        {
            "name": "treat|@CHEMICAL_crizanlizumab|@DISEASE_Anemia_Sickle_Cell"
        },
        {
            "name": "treat|@CHEMICAL_voxelotor|@DISEASE_Anemia_Sickle_Cell"
        }
    ]
}